Amarin reported $95.02M in Operating Expenses for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
DBV Technologies DBVT:US USD 20.09M 5.26M
Abbvie ABBV:US USD 10.21B 1.08B
Aerie Pharmaceuticals AERI:US USD 62.8M 11.35M
Alnylam Pharmaceuticals ALNY:US USD 598.93M 182.43M
Amarin AMRN:US USD 95.02M 62.25M
AstraZeneca AZN:LN USD 9.74B 495M
Biocryst Pharmaceuticals BCRX:US USD 93.27M 6.98M
Esperion Therapeutics ESPR:US USD 60.6M 10.61M
GlaxoSmithKline GSK:LN GBP 6.64B 790M
Halozyme Therapeutics HALO:US USD 128.4M 10.09M
Heron Therapeutics HRTX:US USD 68.44M 8.69M
Intercept Pharmaceuticals ICPT:US USD 179.49M 94.37M
IONIS PHARMACEUT IONS:US USD 218.92M 384K
JAZZ PHA JAZZ:US USD 915.89M 68.56M
Nektar Therapeutics NKTR:US USD 77.93M 96.49M
Neurocrine Biosciences NBIX:US USD 300.1M 93.4M
Novartis NOVN:VX USD 10.67B 183M
Teva Pharmaceutical Industries TEVA:US USD 3.18B 1.56B